GlassScriptPhysician profile
Hans C Brockhoff
NPI 1679747570
$5,653.57
in general payments reported to CMS, 2019-2025
19 companies · $487 in 2025
The $487 reported for 2025 was more than what 78% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $340 · 2020: $259 · 2021: $365 · 2022: $1,140 · 2023: $1,337 · 2024: $1,726 · 2025: $487.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,431 · Travel and Lodging: $1,119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,430.61 |
| Travel and Lodging | $1,119.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $2,616.22 | 2019-2025 | |
| Axogen | $720.34 | 2019-2025 | Avance Nerve Graft, Axoguard Ha+ Nerve Protector, Axoguard Nerve Protector |
| Straumann USA LLC | $658.79 | 2020-2023 | |
| Depuy Synthes Sales INC. | $598.82 | 2019-2025 | Trumatch, Na |
| Stryker Corporation | $411.93 | 2020-2022 | |
| Nobel Biocare USA | $158.03 | 2019-2023 | Nobelactive |
| Merck Sharp & Dohme LLC | $99.84 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $74.20 | 2023-2025 | Enhertu, Calquence, Tagrisso |
| Kerecis Limited | $64.96 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Medtronic, INC. | $40.26 | 2024 | Pteye Parathyroid Detection System |
| Janssen Biotech, INC. | $38.45 | 2024 | Tecvayli, Talvey |
| Gilead Sciences, INC. | $30.03 | 2025 | Trodelvy |
| Biohorizons Implant Systems INC. | $27.28 | 2019 | |
| Daiichi Sankyo INC. | $23.60 | 2023 | Enhertu |
| Integra Lifesciences Corporation | $19.78 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $19.36 | 2023 | Somatuline Depot, Onivyde |
| Tolmar, INC. | $18.74 | 2023 | |
| Tempus Ai, INC | $17.52 | 2024 | |
| Acell, INC. | $15.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hans Brockhoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.